0000885590-11-000010.txt : 20110308
0000885590-11-000010.hdr.sgml : 20110308
20110308212859
ACCESSION NUMBER: 0000885590-11-000010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110304
FILED AS OF DATE: 20110308
DATE AS OF CHANGE: 20110308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Provencio Norma Ann
CENTRAL INDEX KEY: 0001343811
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 11673530
MAIL ADDRESS:
STREET 1: 1041 WEST BADILLO STEET, SUITE 112
CITY: COVINA, CA
STATE: CA
ZIP: 91722
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7150 MISSISSAUGA ROAD
STREET 2: MISSISSAUGA
CITY: ONTARIO
STATE: A6
ZIP: 00000
BUSINESS PHONE: 905 286-3000
MAIL ADDRESS:
STREET 1: 7150 MISSISSAUGA ROAD
STREET 2: MISSISSAUGA
CITY: ONTARIO
STATE: A6
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0303
4
2011-03-04
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001343811
Provencio Norma Ann
7150 MISSISSAUGA ROAD
MISSISSAUGA
A6
L5N 8M5
ONTARIO, CANADA
1
0
0
0
Common Stock, no par value
2011-03-04
4
P
0
1000
39.87
A
117404
D
Common Stock, no par value
2011-03-04
4
P
0
195
39.88
A
117599
D
Common Stock, no par value
2011-03-04
4
P
0
380
39.88
A
117979
D
Deferred Share Units
2011-03-05
4
A
0
2517
0
A
Common Stock, no par value
2517
2517
D
Common stock held in the reporting person's 401k account.
Includes 102,353 Restricted Share Units ("RSUs") held by the reporting person as compensation for her services on the Board of Directors of the issuer, including 3,423 RSUs received as dividend equivalents as a result of a dividend paid on the common stock, no par value, of Valeant Pharmaceuticals International, Inc. on December 22, 2010.
Common stock held in the reporting person's IRA.
Each Deferred Share Unit entitles its holder, upon ceasing to be a director, to receive an amount of cash having the same value as one share of common sock, no par value of Valeant Pharmaceuticals International, Inc., at such time.
/s/ By: Angie Palmer For: Norma Provencio
2011-03-08